BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32152914)

  • 1. Good overall behavioural adjustment in children and adolescents with classic congenital adrenal hyperplasia.
    Messina V; Hirvikoski T; Karlsson L; Vissani S; Wallensteen L; Ortolano R; Balsamo A; Nordenström A; Lajic S
    Endocrine; 2020 May; 68(2):427-437. PubMed ID: 32152914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.
    Hirvikoski T; Nordenström A; Lindholm T; Lindblad F; Ritzén EM; Wedell A; Lajic S
    J Clin Endocrinol Metab; 2007 Feb; 92(2):542-8. PubMed ID: 17148562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive Function of Children and Adolescents With Congenital Adrenal Hyperplasia: Importance of Early Diagnosis.
    Messina V; Karlsson L; Hirvikoski T; Nordenström A; Lajic S
    J Clin Endocrinol Metab; 2020 Mar; 105(3):e683-91. PubMed ID: 31927590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish children and adolescents at risk of congenital adrenal hyperplasia.
    Wallensteen L; Karlsson L; Messina V; Gezelius A; Sandberg MT; Nordenström A; Hirvikoski T; Lajic S
    Horm Behav; 2018 Feb; 98():219-224. PubMed ID: 29410007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of prenatally treated children at risk for congenital adrenal hyperplasia: does dexamethasone cause behavioural problems?
    Hirvikoski T; Nordenström A; Lindholm T; Lindblad F; Ritzén EM; Lajic S
    Eur J Endocrinol; 2008 Sep; 159(3):309-16. PubMed ID: 18579553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and social function in girls with congenital adrenal hyperplasia -- influence of prenatally administered dexamethasone.
    Maryniak A; Ginalska-Malinowska M; Bielawska A; Ondruch A
    Child Neuropsychol; 2014; 20(1):60-70. PubMed ID: 23186079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RETRACTED: Evaluation of behavioral problems after prenatal dexamethasone treatment in Swedish adolescents at risk of CAH.
    Wallensteen L; Zimmermann M; Sandberg MT; Gezelius A; Nordenström A; Hirvikoski T; Lajic S
    Horm Behav; 2016 Sep; 85():5-11. PubMed ID: 27373757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone.
    Wallensteen L; Zimmermann M; Thomsen Sandberg M; Gezelius A; Nordenström A; Hirvikoski T; Lajic S
    J Clin Endocrinol Metab; 2016 Oct; 101(10):3838-3846. PubMed ID: 27482827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive outcome of offspring from dexamethasone-treated pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Meyer-Bahlburg HF; Dolezal C; Haggerty R; Silverman M; New MI
    Eur J Endocrinol; 2012 Jul; 167(1):103-10. PubMed ID: 22549088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender role behaviour in prenatally dexamethasone-treated children at risk for congenital adrenal hyperplasia--a pilot study.
    Hirvikoski T; Lindholm T; Lajic S; Nordenström A
    Acta Paediatr; 2011 Sep; 100(9):e112-9. PubMed ID: 21388450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and motor development of children with and without congenital adrenal hyperplasia after early-prenatal dexamethasone.
    Meyer-Bahlburg HF; Dolezal C; Baker SW; Carlson AD; Obeid JS; New MI
    J Clin Endocrinol Metab; 2004 Feb; 89(2):610-4. PubMed ID: 14764770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory Blood Pressure Monitoring in Children and Adults Prenatally Exposed to Dexamethasone Treatment.
    Karlsson L; Wallensteen L; Nordenström A; Krmar RT; Lajic S
    J Clin Endocrinol Metab; 2022 May; 107(6):e2481-e2487. PubMed ID: 35148399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal dexamethasone treatment in pregnancies at risk for congenital adrenal hyperplasia due to 21-hydroxylase deficiency: effect on midgestational amniotic fluid steroid levels.
    Dörr HG; Sippell WG
    J Clin Endocrinol Metab; 1993 Jan; 76(1):117-20. PubMed ID: 8421074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal dexamethasone treatment in the context of at risk CAH pregnancies: Long-term behavioral and cognitive outcome.
    Karlsson L; Nordenström A; Hirvikoski T; Lajic S
    Psychoneuroendocrinology; 2018 May; 91():68-74. PubMed ID: 29529521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First Trimester DEX Treatment Is Not Associated with Altered Brain Activity During Working Memory Performance in Adults.
    Van't Westeinde A; Zimmermann M; Messina V; Karlsson L; Padilla N; Lajic S
    J Clin Endocrinol Metab; 2020 Nov; 105(11):e4074-82. PubMed ID: 32869847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in adolescents and adults with congenital adrenal hyperplasia.
    Karlsson L; Gezelius A; Nordenström A; Hirvikoski T; Lajic S
    Clin Endocrinol (Oxf); 2017 Dec; 87(6):651-659. PubMed ID: 28771762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in children with congenital adrenal hyperplasia.
    Halper A; Hooke MC; Gonzalez-Bolanos MT; Vanderburg N; Tran TN; Torkelson J; Sarafoglou K
    Health Qual Life Outcomes; 2017 Oct; 15(1):194. PubMed ID: 28985742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perturbed Beta-Cell Function and Lipid Profile After Early Prenatal Dexamethasone Exposure in Individuals Without CAH.
    Wallensteen L; Karlsson L; Messina V; Nordenström A; Lajic S
    J Clin Endocrinol Metab; 2020 Jul; 105(7):e2439-48. PubMed ID: 32433752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced short term memory in congenital adrenal hyperplasia (CAH) and its relationship to spatial and quantitative performance.
    Collaer ML; Hindmarsh PC; Pasterski V; Fane BA; Hines M
    Psychoneuroendocrinology; 2016 Feb; 64():164-73. PubMed ID: 26677764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.